AstraZeneca Aktie
124,40
EUR
-0,55
EUR
-0,44
%
124,50
EUR
-0,70
EUR
-0,56
%
Werbung
AstraZeneca Aktie Analyse
| 30.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 10.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 03.04.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 01.04.19 | AstraZeneca overweight | Barclays Capital | |
| 01.04.19 | AstraZeneca buy | Deutsche Bank AG | |
|
Werbung
|
|||
| 29.03.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.03.19 | AstraZeneca overweight | Barclays Capital | |
| 29.03.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.03.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.02.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.02.19 | AstraZeneca overweight | Barclays Capital | |
| 25.02.19 | AstraZeneca overweight | Barclays Capital | |
| 18.02.19 | AstraZeneca buy | Deutsche Bank AG | |
| 15.02.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 14.02.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.01.19 | AstraZeneca buy | Deutsche Bank AG | |
| 02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.12.18 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 07.12.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 19.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
| 09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.11.18 | AstraZeneca overweight | Barclays Capital | |
| 30.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.10.18 | AstraZeneca buy | Deutsche Bank AG | |
| 19.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.10.18 | AstraZeneca buy | Deutsche Bank AG | |
| 26.09.18 | AstraZeneca buy | Deutsche Bank AG | |
| 25.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 18.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 11.09.18 | AstraZeneca Outperform | BNP PARIBAS | |
| 07.09.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 30.08.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 10.08.18 | AstraZeneca overweight | Barclays Capital | |
| 07.08.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.08.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 30.07.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 27.07.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 27.07.18 | AstraZeneca overweight | Barclays Capital | |
| 27.07.18 | AstraZeneca buy | Deutsche Bank AG | |
Werbung
Werbung